New anticancer agents.
Weiss
G R
GR
Arteaga
C L
CL
Brown
T D
TD
Craig
J B
JB
Harman
G S
GS
Havlin
K A
KA
Koeller
J M
JM
Kuhn
J G
JG
Von Hoff
D D
DD
D000225:Adenine; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use; D047630:Depsipeptides; D004448:Echinomycin / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D005419:Flavonoids / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007094:Imides; D007546:Isoquinolines / Q000627:therapeutic use; D017290:Menogaril; D053644:Naphthalimides; D009621:Nogalamycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D063065:Organophosphonates; D015649:Pentostatin / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives / Q000627:therapeutic use; D011798:Quinaldines
D000225:Adenine; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D047630:Depsipeptides; D004448:Echinomycin; D015251:Epirubicin; D005419:Flavonoids; D006146:Guanidines; D015255:Idarubicin; D007094:Imides; D007546:Isoquinolines; D017290:Menogaril; D053644:Naphthalimides; D009621:Nogalamycin; D063065:Organophosphonates; D015649:Pentostatin; D010456:Peptides, Cyclic; D011108:Polymers; D001084:Vidarabine Phosphate; C037020:amonafide; C042382:fludarabine phosphate; C030051:didemnins; C046943:brequinar; D011798:Quinaldines; C049328:flavone acetic acid; C022084:carboxyimamidate; C037258:gusperimus